The determination of pharmacokinetic-link and pharmacodynamic parameters of rocuronium with different pharmacokinetic models

Huang Yonglei,Zhou Renlong,Zhang Mazhong

DOI: https://doi.org/10.3969/j.issn.1004-5805.2006.12.007

2006-01-01

Abstract:Objective To determine the pharmacokinetic-link and pharmacodynamic parameters of rocuronium with different pharmacokinetic models. Methods Twenty-two ASA class Ⅰor Ⅱ patients scheduled for selective surgery received rocuronium 0.03mg·kg -1 ·min -1 up to TOF ratio of 20%-30%. The theoretical plasma concentration versus time was calculated for all patients based on pharmacokinetic models described by Cooper, Szenohradszkay, Alvare-Gomez and Wierda. Predicted effect versus time was calculated following the pharmacokinetic-pharmacodynamic link model. Pharmacokinetic-link parameter(ke0)and pharmacodynamic parameters(EC_ 50 ,γ)were estimated by fitting a sigmoid cure. We also calculate objective functions of different pharmacokinetic models with estimated parameters. Results The ke0, EC_ 50 and γ of Cooper model were 0.190±0.054/min,0.810±0.196μg/ml and 4.534±1.021, of Szenohradszkay 0.503±0.222/min,0.996±0.242μg/ml and 5.964±1.442, of Alvare-Gomez 0.265±0.077/min,0.729±0.177μg/ml and 4.941±1.129, and of Wierda 0.216±0.062/min,0.845±0.206g/ml and 4.587±1.001. The objective functions were 2686 ± 1909, 4506 ± 3063, 3084 ± 2193 and 2961 ± 2258 with Cooper, Szenohradszkay, Alvare-Gomez and Wierda models, respectively. There was a significant difference in the objective functions between Szenohradszkay model and those of Cooper, Alvarez-Gomez and Wierda models. Conclusion There are different pharmacokinetic link and pharmacodynamic characteristic with different pharmacokinetic models.